Vienna, Austria

ESTRO 2025

Session

Saturday
May 03
08:45 - 10:00
Lehar 1-3
In-vivo treatment verification in particle therapy: Quo vadis?
Edmond Sterpin, Belgium;
Vlad Badiu, The Netherlands
In particle therapy, accurately determining where particles stop in the patient is crucial to ensure safer and more precise treatments. Over the past decade, various technological solutions have been proposed, but no industrial system for large-scale in vivo treatment verification is currently available. Prof. Katia Parodi will present an overview of these solutions, while Prof. Christian Richter will discuss existing clinical data, emphasizing the real-world impact and importance of integrating verification into clinical workflows. Prof. Thomas Bortfeld will highlight how verification could enable innovative treatment techniques. Dr. Julien Smeets will conclude by addressing the technical and industrial challenges of integrating these systems into complex and evolving particle therapy platforms, including considerations for proton arc therapy and FLASH.
Symposium
Physics
Dosimetry & QA
08:45 - 09:03
Overview of existing solutions and research
Katia Parodi, Germany
E25-4700
09:03 - 09:21
Hard facts: Clinical experience with in vivo treatment verification
Christian Richter, Germany
E25-4702
09:21 - 09:39
Is there a killer application for in vivo treatment verification?
Thomas Bortfeld, USA
E25-4701
09:39 - 09:57
What's required to make TV a clinical product?
Julien Smeets, Belgium
E25-4703